Lidocaine topical gel - Pharmanest

Drug Profile

Lidocaine topical gel - Pharmanest

Alternative Names: SHACT

Latest Information Update: 02 Sep 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Pharmanest
  • Class Acetanilides; Analgesics; Class Ib antiarrhythmics; Local anaesthetics; Small molecules
  • Mechanism of Action Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Procedural pain

Most Recent Events

  • 02 Sep 2015 Phase-II development for Procedural pain is ongoing in Sweden
  • 24 Sep 2013 Biomarkers information updated
  • 07 Sep 2013 Pharmanest completes a phase II trial for Procedural pain in Sweden (EudraCT2013-001775-20)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top